IN THE NEWS

Novo Nordisk

4January2022

Novo Holdings to acquire Ritedose

COPENHAGEN, Denmark, Jan. 4, 2022 /PRNewswire/ – Founded in 1995 and headquartered in Columbia, S.C., The Ritedose Corporation (“Ritedose”) is a leading sterile pharmaceutical manufacturer, specialising in the use of blow-fill-seal (BFS) technology. Ritedose provides outsourced development and manufacturing of…

FEATURED NEWS

15th April 2025

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre

single-vial packaging line in manufacturing facility

16th September 2024

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

Ohtuvayre box with two individually wrapped vials with text overlay: development and manufacturing partner

11th July 2024

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand f…

interior of large warehouse with forklifts in foreground and text overlay: we are expanding

18th January 2022

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser SuredoseRx™ to launch in first quarter

an array of liquid tubes and packaging featuring Ritedose's SuredoseRx shown in front of a factory with text overlay: precision dosing made easy

4th January 2022

Novo Holdings to acquire Ritedose

3rd August 2021

Ritedose Efficiency Innovation Yields Up to 25% Increase in CDMO Production Capability

pharmaceutical production line with several products being processed by machinery with text overlay: meeting surge demands With engineering breakthroughs

RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

TAGS CLOUD